Clinical Trials – The Bloodline with LLS
Clinical Trials - The Bloodline with LLS
Podcast Description
A Podcast for Patients and Caregivers
Podcast Insights
Content Themes
The podcast focuses on a variety of critical cancer-related topics, including CAR T-cell therapy, challenges in treating acute myeloid leukemia (AML), and the evolving landscape of myeloma treatment. Episodes delve into specific conditions and treatments, featuring interviews that answer pressing questions from patients and caregivers, such as eligibility criteria and side effects of new therapies.
A Podcast for Patients and Caregivers
In this episode, we are joined by Dr. Abdulraheem Yacoub of The University of Kansas Cancer Center to discuss myeloproliferative neoplasms (MPN), a group of rare blood cancers that affect how blood cells are produced. We explore what MPNs are, the most common types, and the signs and symptoms that lead to diagnosis. We also answer real questions from members of our MPN online chat community, covering topics like life expectancy, genetic mutations, and managing side effects. Finally, we discuss current treatment options, emerging therapies, and share a message of hope for patients and their loved ones.
CLICK HERE to participate in our episode survey.
Mentioned on this episode:
- Myeloproliferative neoplasms (MPN)
- MPN Online Chat
- MPN-SAF Symptom Assessment Form
- MPN Research Consortium Tissue Bank
- Bispecific antibody/immunotherapy fact sheet
- CAR T-cell therapy
Additional LLS Support Resources:
- Free Nutrition Consultations
- Information Specialists
- Free telephone/web patient programs
- Clinical Trial Support Center
- Advocacy and Public Policy
- Free booklets
- Financial support
- Young Adult Resources
- Support groups
- Survivorship Workbook
- Community
- Caregiver support
- Caregiver Workbook
- Mental Health Resources
Supported by PharmaEssentia USA Corporation.
The post After Diagnosis: Finding Hope with Myeloproliferative Neoplasms first appeared on The Bloodline with Blood Cancer United Podcast.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.